Cargando…
Formulation Development and Evaluation of the Therapeutic Efficacy of Brinzolamide Containing Nanoemulsions
Brinzolamide (BZ) is an intraocular pressure reducing agent with low bioavailability. The purpose of the present study was to overcome this issue by development of BZ containing nanoemulsions (NEs) as an ocular drug delivery system with desirable therapeutic efficacy. Brinzolamide NEs were prepared...
Autores principales: | Mahboobian, Mohammad Mehdi, Seyfoddin, Ali, Rupenthal, Ilva D., Aboofazeli, Reza, Foroutan, Seyed Mohsen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610741/ https://www.ncbi.nlm.nih.gov/pubmed/29201076 |
Ejemplares similares
-
Nanometric-Scaled Emulsions (Nanoemulsions)
por: Aboofazeli, Reza
Publicado: (2010) -
Formulation Development and Toxicity Assessment of Triacetin Mediated Nanoemulsions as Novel Delivery Systems for Rapamycin
por: Sobhani, Hamideh, et al.
Publicado: (2015) -
Rapamycin-Loaded, Capryol(TM) 90 and Oleic Acid Mediated Nanoemulsions: Formulation Development, Characterization and Toxicity Assessment
por: Sobhani, Hamideh, et al.
Publicado: (2018) -
Formulation Considerations for the Management of Dry Eye Disease
por: Agarwal, Priyanka, et al.
Publicado: (2021) -
The Efficacy, Safety, and Satisfaction Associated with Switching from Brinzolamide or Brimonidine to Brinzolamide/Brimonidine in Open-Angle Glaucoma Patients
por: Onoe, Hiromitsu, et al.
Publicado: (2022)